Oxytocin Antagonist in Patients With Repeated Failure of Implantation

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AZ Jan Palfijn Gent
• Collaborator: Onze Lieve Vrouw Hospital
• Treatments: Atosiban; Oxytocin; Vasotocin

Criteria

Inclusion Criteria:

• IVF/ ICSI patients below 38 years

• 2e to 6e IVF-cycle

Exclusion Criteria:

• patients with endocrinological diseases or problems